(IBC)

Biosafety

Investigative New Animal Drug

The FDA INAD has a fee schedule for registering the use of investigative new animal drugs. http://www.fda.gov/cvm/aboutona.htm

Any investigator who plans to utilize an investigative new animal drug as part of their research should coordinate their communications with FDA through the Research Compliance Office 335-1585.

This communication is necessary to ensure that the appropriate waivers and exemptions with FDA Guidelines for Industry 170 "Animal Drug User Fees and Fee Waivers and Reductions" are applied. Also, any faculty member applying for an INAD or causing the FDA to open an existing INAD file (such as for a revision, etc…) significant fees may be incurred.
Office of Research Assurances, P.O. Box 643005, Washington State University, Pullman WA 99164-3005
WSU Biosafety Officer: Lorraine McConnell lorrmcc@wsu.edu Phone: 509-335-4462, Fax: 509-335-6410
Director of Research Assurances: Dave Clark drclark@wsu.edu Phone: 509-335-1585